Vallé-Jones J C, Brodie N H, O'Hara H, O'Hara J, McGhie R L
Pharmatherapeutica. 1983;3(5):300-4.
A study was carried out in general practice to compare the effectiveness and tolerance of phentermine and diethylpropion in helping patients more than 20% above their desirable weight to lose weight. Patients were allocated at random to receive either one 30 mg capsule of phentermine (50 patients) or one 75 mg tablet of diethylpropion (49 patients) daily over a period of 12 weeks. They were also asked to restrict their calorie intake to 1500 calories per day. The results showed that there was a significantly greater weight loss in patients treated with phentermine which was particularly marked during the last 4 weeks of the study. There were significant reductions in blood pressure and heart rate in the phentermine group and of heart rate in the diethylpropion group. These were almost certainly related to weight loss rather than to a direct effect of drug treatment. Side-effects were generally minor in nature and the incidence and nature of them were comparable in the two groups.
在普通医疗实践中开展了一项研究,以比较苯丁胺和安非拉酮在帮助体重超过理想体重20%以上的患者减肥方面的有效性和耐受性。患者被随机分配,一组每天服用一粒30毫克的苯丁胺胶囊(50名患者),另一组每天服用一片75毫克的安非拉酮片(49名患者),为期12周。他们还被要求将每日卡路里摄入量限制在1500卡路里。结果显示,接受苯丁胺治疗的患者体重减轻更为显著,在研究的最后4周尤为明显。苯丁胺组的血压和心率显著降低,安非拉酮组的心率显著降低。这些几乎肯定与体重减轻有关,而非药物治疗的直接作用。副作用一般性质轻微,两组的副作用发生率和性质相当。